Sagimet Biosciences (SGMT)

Profile

Full Name

Sagimet Biosciences Inc.

Ticker Symbol

SGMT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 17, 2023

Indexes

Not included

Website

http://www.sagimet.com

Employees

14

Key Details

Price

$3.33(+4.06%)

Market cap

$107.21M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.45(+45.49% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.33
    SGMT price is $3.33

    30-Day Relative Volume

    1.10
    SGMT 30-day relative volume is 1.10

    Price Performance

    Price Today change

    +4.06%
    SGMT price is up +4.06% today

    Price YTD change

    -26%
    SGMT price is down -26% since January 1st

    Price 1-year change

    -27.13%
    SGMT price is down -27.13% year-on-year

    Price 3-year change

    -
    SGMT price 3-year change is unknown

    Price Range

    Price All-time high

    $20.71
    SGMT price is currently -83.92% below its historical high of $20.71

    Price 3-year low

    $1.73
    SGMT price is currently +92.49% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $107.21M
    SGMT market capitalization is $107.21 million

    Market cap 3-year change

    -
    SGMT market capitalization 3-year change is unknown

    Market cap All-time high

    $412.13M
    SGMT market capitalization is currently -73.99% below its historical high of $412.13 million

    Market cap sector rank

    47.76%
    SGMT market capitalization is higher than 47.76% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.88%
    SGMT shares outstanding is up +0.88% year-on-year

    Shares Outstanding 3-Year Change

    -
    SGMT shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.86
    SGMT beta is 1.86

    200-day SMA

    $4.00
    SGMT price is currently -16.70% below its 200-day simple moving average

    50-day SMA

    $3.19
    SGMT price is currently +4.37% above its 50-day simple moving average

    RSI

    51.22
    SGMT 14-day relative strength index is 51.22

    Volume

    1.10
    SGMT 30-day relative volume is 1.10

    ATR

    $0.31
    SGMT average true range is $0.31

    10-day Historical Volatility

    102.79%
    SGMT 10-day historical volatility is 102.79%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    SGMT annual revenue value is unknown

    Revenue Analysts estimate

    $1.25M
    SGMT annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    SGMT annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    SGMT annual revenue is unknown

    EPS

    EPS

    -$1.45
    SGMT annual earnings per share is -$1.45

    EPS Analysts estimate

    -$3.40
    SGMT annual earnings per share is currently -57.35% lower than the consensus analysts' forecast

    EPS 1-year change

    +45.49%
    SGMT annual earnings per share is up +45.49% year-on-year

    EPS Sector rank

    46.42%
    SGMT annual earnings per share is higher than 46.42% of companies in Healthcare sector

    Profit

    Gross profit

    -
    SGMT annual gross profit value is unknown

    Gross margin

    -
    SGMT annual gross profit margin value is unknown

    Operating profit

    -$54.45M
    SGMT annual operating income is -$54.45 million

    Operating margin

    -
    SGMT annual operating profit margin value is unknown

    Net income

    -$45.57M
    SGMT annual net profit is -$45.57 million

    Net margin

    -
    SGMT annual net profit margin value is unknown

    Expenses

    Total expenses

    $54.45M
    SGMT annual total expenses is $54.45 million

    Operating expenses

    $54.45M
    SGMT annual total operating expenses is $54.45 million

    Cost of goods sold

    -
    SGMT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $16.01M
    SGMT annual SGA is $16.01 million

    Depreciation and amortization

    -
    SGMT annual depreciation & amortization value is unknown

    Interest expense

    -
    SGMT annual interest expense value is unknown

    Income tax

    -
    SGMT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$54.45M
    SGMT annual earnings before interest & taxes is -$54.45 million

    EBITDA

    -$54.45M
    SGMT annual EBITDA is -$54.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $160.26M
    SGMT annual total assets is $160.26 million

    Non current assets

    $7.49M
    SGMT annual long term assets is $7.49 million

    Current assets

    $152.77M
    SGMT annual total current assets is $152.77 million

    Cash and cash equivalents

    $75.84M
    SGMT annual cash & cash equivalents is $75.84 million

    Accounts receivable

    -
    SGMT annual accounts receivable value is unknown

    Inventory

    -
    SGMT annual inventory value is unknown

    Liabilities

    Total liabilities

    $4.45M
    SGMT annual total liabilities is $4.45 million

    Long term liabilities

    $0.00
    SGMT annual total long term liabilities is $0.00

    Current liabilities

    $4.45M
    SGMT annual total current liabilities is $4.45 million

    Accounts payable

    $1.43M
    SGMT annual accounts payable is $1.43 million

    Debt

    Total debt

    $78.00K
    SGMT annual total debt is $78.00 thousand

    Total debt 1-year change

    +20%
    SGMT annual total debt is up +20% year-on-year

    Long term debt

    -
    SGMT annual long term debt value is unknown

    Short term debt

    $78.00K
    SGMT annual short term debt is $78.00 thousand

    Equity & Capital

    Shareholders equity

    $155.81M
    SGMT annual stockholders equity is $155.81 million

    Book value

    $155.81M
    SGMT annual book value is $155.81 million

    Retained earnings

    -$295.31M
    SGMT annual retained earnings is -$295.31 million

    Working capital

    $148.32M
    SGMT annual working capital is $148.32 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$42.44M
    SGMT annual cash flow from operations is -$42.44 million

    Cash from operations 1-year change

    -78.55%
    SGMT annual cash flow from operations is down -78.55% year-on-year

    Cash from investing

    -$61.68M
    SGMT annual cash flow from investing activities is -$61.68 million

    Cash from investing 1-year change

    -590.33%
    SGMT annual cash flow from investing activities is down -590.33% year-on-year

    Cash from financing

    $104.82M
    SGMT annual cash flow from financing activities is $104.82 million

    Cash from financing 1-year change

    +21.65%
    SGMT annual cash flow from financing activities is up +21.65% year-on-year

    CAPEX

    CAPEX

    -
    SGMT annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    SGMT annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$42.44M
    SGMT annual free cash flow is -$42.44 million

    Free cash flow 1-year change

    -78.55%
    SGMT annual free cash flow is down -78.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SGMT annual gross profit margin value is unknown

    Operating margin

    -
    SGMT annual operating profit margin value is unknown

    Net margin

    -
    SGMT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -28.43%
    SGMT annual return on assets is -28.43%

    ROE

    -29.25%
    SGMT annual return on equity is -29.25%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SGMT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SGMT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.69
    SGMT price to book ratio is 0.69

    PB ratio Sector rank

    34.8%
    SGMT price to book ratio is higher than 34.8% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SGMT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SGMT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $31.45M
    SGMT enterprise value is $31.45 million

    Enterprise value Sector rank

    34.59%
    SGMT enterprise value is higher than 34.59% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.58
    SGMT EV/EBITDA is -0.58

    EV/EBITDA Sector rank

    51.66%
    SGMT EV/EBITDA is higher than 51.66% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    34.30
    SGMT annual current ratio is 34.30

    Quick ratio

    -
    SGMT annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    SGMT annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    SGMT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SGMT piotroski f-score value is unknown

    Altman Z-Score

    -
    SGMT altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Mar 13, 25 HC Wainwright & Co.
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Jan 27, 25 Jones Trading
    Buy
    Dec 6, 24 Oppenheimer
    Outperform
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Nov 12, 24 UBS
    Buy
    Oct 31, 24 HC Wainwright & Co.
    Buy
    Oct 2, 24 HC Wainwright & Co.
    Buy
    Aug 15, 24 JMP Securities
    Market Outperform
    Aug 15, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with SGMT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Sagimet Biosciences?
    • Does Sagimet Biosciences pay dividends?
    • What sector is Sagimet Biosciences in?
    • What industry is Sagimet Biosciences in?
    • What country is Sagimet Biosciences based in?
    • When did Sagimet Biosciences go public?
    • Is Sagimet Biosciences in the S&P 500?
    • Is Sagimet Biosciences in the NASDAQ 100?
    • Is Sagimet Biosciences in the Dow Jones?
    • When was Sagimet Biosciences's last earnings report?
    • When does Sagimet Biosciences report earnings?
    • Should I buy Sagimet Biosciences stock now?

    What is the ticker symbol for Sagimet Biosciences?

    The ticker symbol for Sagimet Biosciences is NASDAQ:SGMT

    Does Sagimet Biosciences pay dividends?

    No, Sagimet Biosciences does not pay dividends

    What sector is Sagimet Biosciences in?

    Sagimet Biosciences is in the Healthcare sector

    What industry is Sagimet Biosciences in?

    Sagimet Biosciences is in the Biotechnology industry

    What country is Sagimet Biosciences based in?

    Sagimet Biosciences is headquartered in United States

    When did Sagimet Biosciences go public?

    Sagimet Biosciences's initial public offering (IPO) was on July 17, 2023

    Is Sagimet Biosciences in the S&P 500?

    No, Sagimet Biosciences is not included in the S&P 500 index

    Is Sagimet Biosciences in the NASDAQ 100?

    No, Sagimet Biosciences is not included in the NASDAQ 100 index

    Is Sagimet Biosciences in the Dow Jones?

    No, Sagimet Biosciences is not included in the Dow Jones index

    When was Sagimet Biosciences's last earnings report?

    Sagimet Biosciences's most recent earnings report was on Mar 12, 2025

    When does Sagimet Biosciences report earnings?

    The next expected earnings date for Sagimet Biosciences is May 15, 2025

    Should I buy Sagimet Biosciences stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page